AbbVie

New Speakers from Roche & Imperial College announced for SMi’s ADMET Event

https://pharmaphorum.com/partner-content/new-speakers-from-roche-imperial-college-announced-for-smis-admet-event/

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Top pharmaceutical companies in the world in 2017

https://pharmaphorum.com/views-and-analysis/top-pharmaceutical-companies-world-2017/

More good news for AbbVie in rheumatoid arthritis

https://pharmaphorum.com/news/abbvie-rheumatoid-arthritis/

Fourth Humira biosimilar set for EU approval

https://pharmaphorum.com/news/humira-biosimilar-eu-sandoz-chmp/

ASCO 2018 – Sunday 3rd June: Opdivo/Nektar, AbbVie’s new leukaemia combo, and more

https://pharmaphorum.com/views-analysis-oncology/asco_2018-opdivo-nektar-abbvies-leukaemia/

Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snippet for ADMET

https://pharmaphorum.com/partner-content/dr-eric-blomme-abbvie-chair-invite-interview-snippet-for-admet/

Biogen gets go-ahead for EU Humira launch in October

https://pharmaphorum.com/sales-marketing/biogen-gets-go-ahead-eu-humira-launch-october/

AbbVie’s shares tank after cancer hopeful’s phase 2 setback

https://pharmaphorum.com/news/abbvie/

Close in 10 seconds

Pharmaphorum.com

Search